Companies/ExpreS2ion Biotech Holding AB
Follow
ExpreS2ion Biotech Holding AB
Nasdaq First North GM (Sweden)
ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 300 proteins and 40 virus-like particles (VLPs) in collaboration with research institutions and companies.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
www.expres2ionbio.com
Current instruments
Type
Ticker
ISIN
SHARE
EXPRS2
SE0008348262
Nasdaq First North GM Sweden (SE)
OPTION
EXPRS2 TO 4
SE0014958328
Nasdaq First North GM Sweden (SE)
OPTION
EXPRS2 TO 5
SE0014958336
Nasdaq First North GM Sweden (SE)
OPTION
EXPRS2 TO4
SE0014958328
Nasdaq First North GM Sweden (SE)
OPTION
EXPRS2 TO5
SE0014958336
Nasdaq First North GM Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
EXPRS2
SE0008348262
Nasdaq First North GM
Sweden (SE)
Details of share in ExpreS2ion Biotech Holding AB with ticker EXPRS2
Status
Active
Order book id
—
Amount of instruments
27 276 485
Par value
0.1111
Market cap
—
Currency
SEK
Segment
First North
First trading date
29 Jun 2016
Terms
—
Type
Price
Pre-money valuation
Time
Files
IPO
5.90 SEK
33.5M SEK
08 Jun - 22 Jun 2016
IPO in ExpreS2ion Biotech Holding AB
Please sign in to view the full information or
Sign up for free
Type
Price
Pre-money valuation
Time
Files
Rights issue
4.50 SEK
3.93M SEK
10 Aug - 24 Aug 2017
Share issue in ExpreS2ion Biotech Holding AB
Please sign in to view the full information or
Sign up for free
Type
Price
Pre-money valuation
Time
Files
Rights issue
8.00 SEK
76.8M SEK
08 Feb - 27 Feb 2018
Share issue in ExpreS2ion Biotech Holding AB
Please sign in to view the full information or
Sign up for free
Type
Price
Pre-money valuation
Time
Files
Directed issue
5.00 SEK
60.01M SEK
28 Feb 2019
Share issue in ExpreS2ion Biotech Holding AB
Please sign in to view the full information or
Sign up for free
Type
Price
Pre-money valuation
Time
Files
Directed issue
6.00 SEK
101.48M SEK
26 Feb 2020
Share issue in ExpreS2ion Biotech Holding AB
Please sign in to view the full information or
Sign up for free
Type
Price
Pre-money valuation
Time
Files
Rights issue
12.00 SEK
196.39M SEK
05 Oct - 19 Oct 2020
Share issue in ExpreS2ion Biotech Holding AB
Please sign in to view the full information or
Sign up for free
Type
Ticker
ISIN
Market
OPTION
EXPRS2 TO 4
SE0014958328
Nasdaq First North GM
Sweden (SE)
Details of option in ExpreS2ion Biotech Holding AB with ticker EXPRS2 TO 4
Status
Active
Order book id
208883
Amount of instruments
5 455 297
Market cap
—
Currency
SEK
Trading period
16 Nov 2020 - 22 Apr 2021
Terms
Three (3) warrants of series TO 4 entitles the holder to subscribe for one (1) share in the Company during the period from April 12, 2021 to April 26, 2021. Strike price for warrants will correspond to 70 percent of the VWAP of the Company's share price on Nasdaq First North Growth Market during the period from March 29, 2021 to April 9, 2021, but at least SEK 6 and a maximum of SEK 22 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00-22.00 SEK
12 Apr - 26 Apr 2021
Option exercise terms for EXPRS2 TO 4
Please sign in to view the full information or
Sign up for free
Type
Ticker
ISIN
Market
OPTION
EXPRS2 TO 5
SE0014958336
Nasdaq First North GM
Sweden (SE)
Details of option in ExpreS2ion Biotech Holding AB with ticker EXPRS2 TO 5
Status
Active
Order book id
208884
Amount of instruments
5 455 297
Market cap
—
Currency
SEK
Trading period
16 Nov 2020 - 16 Sep 2021
Terms
Three (3) warrants of series TO5 entitles the holder to subscribe for one (1) share in the Company during the period from September 6, 2021 to September 20, 2021. Strike price for warrants will correspond to 70 percent of the VWAP of the Company's share on Nasdaq First North Growth Market during the period from August 23, 2021 to September 3, 2021, but at least SEK 6 and a maximum of SEK 25 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00-25.00 SEK
23 Aug - 03 Sep 2021
Option exercise terms for EXPRS2 TO 5
Please sign in to view the full information or
Sign up for free
Type
Ticker
ISIN
Market
OPTION
EXPRS2 TO4
SE0014958328
Nasdaq First North GM
Sweden (SE)
Details of option in ExpreS2ion Biotech Holding AB with ticker EXPRS2 TO4
Status
Active
Order book id
—
Amount of instruments
5 455 297
Market cap
—
Currency
SEK
Segment
First North
Terms
—
Type
Ticker
ISIN
Market
OPTION
EXPRS2 TO5
SE0014958336
Nasdaq First North GM
Sweden (SE)
Details of option in ExpreS2ion Biotech Holding AB with ticker EXPRS2 TO5
Status
Active
Order book id
—
Amount of instruments
5 455 297
Market cap
—
Currency
SEK
Segment
First North
Terms
—
People
Number of Employees
15 people
Bent U. Frandsen
CEO
Martin Roland Jensen
Chairman of the board
Allan Rosetzsky
Board member
Gitte Pedersen
Board member
Jakob Knudsen
Board member
Martin Roland Jensen
Board member
Company Details
Sector
HEALTH CARE
Website
Address
C/O Mazars Set
Zip code
252 78
City/district
Helsingborg
Country
Sweden (SE)
Phones
Email
buf@expres2ionbio.com
Registration number
559033-3729
LEI code
549300FJK50P1ORYJC45
First trade date
29 Jun 2016
Registration date
03 Nov 2015
Short name
ExpreS2ion Biotech

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date